A review of the vaccine Adverse Event Reporting System database

Expert Opinion on Pharmacotherapy

Volumn 5, Issue 3, 2004, Pages 691-698

  Geier, David A ^b   Geier, Mark R ^a  

^a Genetic Centers of America   (United States)

^b MedCon Inc   (United States)

Author keywords

DTaP; DTP; Lyme; Rotavirus; Rubella; Thimerosal; Vaccine; VAERS

Indexed keywords

BACTERIAL VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; INFLUENZA VACCINE; LYME DISEASE VACCINE; MEASLES MUMPS RUBELLA VACCINE; ROTAVIRUS VACCINE; RUBELLA VACCINE; THIOMERSAL; VIRUS VACCINE;

ARTHRALGIA; ARTHROPATHY; AUTISM; BODY WEIGHT DISORDER; BRAIN INJURY; CEREBELLAR ATAXIA; CHRONIC ARTHRITIS; CLINICAL OBSERVATION; DEVELOPMENTAL DISORDER; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE CONTROL; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EXPERIMENTAL DESIGN; FACTUAL DATABASE; FLU LIKE SYNDROME; FOOD AND DRUG ADMINISTRATION; GASTROENTERITIS; GASTROINTESTINAL HEMORRHAGE; GUILLAIN BARRE SYNDROME; HEALTH PROGRAM; HUMAN; INFANTILE SPASM; INTESTINE INTUSSUSCEPTION; JOINT STIFFNESS; LYMPHADENOPATHY; MASS IMMUNIZATION; MEDICAL INFORMATION SYSTEM; MEDICAL LITERATURE; MENTAL DEFICIENCY; NEUROLOGIC DISEASE; NEUROPATHY; NEUROTOXICITY; NONHUMAN; OSTEOARTHRITIS; PARALYSIS; PREDICTION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; SEIZURE; SPEECH DISORDER; SUDDEN INFANT DEATH SYNDROME; THROMBOCYTOPENIA; VIRUS ENCEPHALITIS; VIRUS IMMUNITY;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATABASES, FACTUAL; HUMANS; UNITED STATES; VACCINES;

EID: 1542400304     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.5.3.691     Document Type: Review

References (45)

1. BRINK EW, HINNMAN AR: The Vaccine Injury Compensation Act: the new law and you. Contemp. Peds. (1989) 6:28-42.
2. CENTERS FOR DISEASE CONTROL AND PREVENTION: National Childhood Vaccine Injury Act: Requirements for permanent vaccination records and for reporting of selected events after vaccination. Morb. Mortal. Wkly Rep. (1988) 37:197-200.
3. CHEN RT, RASTOGI SC, MULLEN JR et al.: The vaccine adverse event reporting system (VAERS). Vaccine (1994) 12:542-550.
4. NIGHTINGALE SL: New system for reporting of vaccine adverse events. J. Am. Med. Assoc. (1990) 264:2863.
5. SINGLETON JA, LLOYD JC, MOOTREY GT, SALIVE ME, CHEN RT: An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group. Vaccine (1999) 17:2908-29017.
6. UNITED STATES FOOD AND DRUG ADMINISTRATION: Coding Symbols for Thesaurus of Adverse Reaction Terms (3rd edn), FDA, Rockville, MD, USA (1989).
7. ZHOU W, POOL V, ISKANDER JK et al.: Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001. Morb. Mortal. Wkly Rep. (2003) 52:1-24.
8. ROSENTHAL S, CHEN R, HADLER S: The safety of acellular pertussis vaccine versus whole-cell pertussis vaccine. A postmarketing assessment. Arch. Pediatr. Adolesc. Med. (1996) 150-457-460.
9. CHEN RT, ROSENTHAL S: An errant critique that misses the mark. Arch. Pediatr. Adolesc. Med. (1996) 150:464-465.
10. GEIER MR, GEIER DA: Vaccine causation of selected adverse reactions: Epidemiology of the vaccine adverse event reporting system (VAERS). Thimerosal & Vaccines (2002) 1(1):32-42.
11. EDWARDS KM, DECKER MD, MORTIMER EA: Pertussis vaccine. In: Vaccines (3rd edn). Orenstein WA, Plotkin SA (Eds), WB Saunders Company, New York, USA (1999):293-344.
12. GEIER D, GEIER M: The true story ofApertussis vaccination: a sordid legacy? J. Hist. Med. Allied Sci. (2002) 57:249-284.
13. MILLER D, WADSWORTH, ROSS E: Severe neurological illness: further analyses of the British National Childhood Encephalopathy Study. Tokai J. Exp. Clin. Med. (1988) 13(Suppl.):145-155.
14. MILLER D, MADGE N, DIAMOND J, WADSWORTH J, ROSS E: Pertussis immunization and serious acute neurological illnesses in children. Br. Med. J. (1993) 307:1171-1176.
15. INSTITUTE OF MEDICINE (US). Adverse Effects of Pertussis and Rubella Vaccines National Academy Press, Washington, DC, USA (1991).
16. INSTITUTE OF MEDICINE (US): DPT vaccine and chronic nervous system dysfunction: A new analysis National Academy Press, Washington, DC, USA (1994).
17. INSTITUTE OF MEDICINE (US): New Vaccine Development: Establishing Priorities: National Academy Press, Washington, DC, USA (1985).
18. GEIER DA, GEIER MR: Serious neurological conditions following pertussis immunization: An analysis of endotoxin levels, the vaccine adverse events reporting system (VAERS) database and literature review. Pediatr. Rehabil. (2002) 5:177-182.
19. GEIER DA, GEIER MR: Clinical implications of endotoxin concentrations in vaccines. Ann. Pharmacother. (2002) 36:776-780.
20. GEIER DA, GEIER MR: An evaluation of serious neurological disorders following immunization: A comparison of whole-cell pertussis and acellular pertussis vaccines. Brain Dev. (In Press).
21. GEIER DA, GEIER MR: Rubella vaccine and arthritic adverse reactions: An analysis of the vaccine adverse events reporting system (VAERS) database from 1991 through 1998. Clin. Exp. Rheumatol. (2001) 19:724-726.
22. GEIER DA, GEIER MR: A one year follow-up of chronic arthritis following rubella and hepatitis B vaccination based upon analysis of the vaccine adverse events reporting system (VAERS) database. Clin. Exp. Rheumatol. (2002) 20:767-771.
23. INSITUTE OF MEDICINE (US): Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Casuality. National Academy Press, Washington, DC, USA (1994).
24. WEIBEL RE, CASERTA V, BENOR DE, EVABS G: Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: A review of claims submitted to the national vaccine injury compensation program. Pediatrics (1998) 101:383-387.
25. LANDRIGAN PJ, WITTE JJ: Neurologic disorders following live measles-virus vaccination. JAMA (1973) 223:1459-1462.
26. ALLERDIST H: Neurological complications following measles vaccination. Dev. Biol. Stand. (1979) 43:259-264.
27. DEPARTMENT OF HHS (UK). Whooping Cough. Her Majestys Stationary Office, London, UK (1981).
28. GEIER DA, GEIER MR: Pediatric MMR vaccine safety. Int. Pediatr. (2003) 19:108-113.
29. GEIER MR, GEIER DA, ZAHALSKY AC: Influenza vaccination and Guillain Barre syndrome. Clin. Immunol. (2003) 107:116-121.
30. SCHONBERGER LB, BREGMAN DJ, SULLIVAN-BOLYAI JZ et al.: Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am. J. Epidemiol. (1979) 110:105-123.
31. CHEN R, KENT P, RHODES P, SIMON P, SCHONBERGER L: Investigation of a possible association between influenza vaccination and Guillain-Barre syndrome in the United States, 1990-91. Post. Mark. Surveill. (1992) 6:5-6.
32. LASKY T, TERRACCIANO GJ, MAGDER L et al.: The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N. Engl. J. Med. (1998) 338:1791-1802.
33. CENTERS FOR DISEASE CONTROL AND PREVENTION: Intussusception among recipients of rotavirus vaccine-United States, 1998-1999. Morb. Mortal. Wkly Rep. (1999) 48:577-581.
34. CENTERS OF DISEASE CONTROL AND PREVENTION: Withdrawal of rotavirus vaccine recommendation. Morb. Mortal. Wkly Rep. (1999) 48:1007.
35. PETER G, MYERS MG: National Vaccine Advisory Committee; National Vaccine Program Office. Intussusception, rotavirus, and oral vaccines: Summary of a workshop. Pediatrics (2002) 110:E67.
36. GEIER DA, GEIER MR: Gastrointestinal reactions and rotavirus vaccination based upon analysis of the Vaccine Adverse Events Reporting System (VAERS) database for 1999. A model for the calculation of the incidence rates and statistical significance of adverse events following immunization. Hepatogastroenterology (2004) 51:477-481.
37. BALL LK, BALL R, PRATT RD: An assessment of thimerosal use in childhood vaccines. Pediatrics (2001) 107:1147-1154.
38. INSTITUTE OF MEDICINE (US): Immunization Safety Review Committe Meeting: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. National Academy Press, Washington, DC, USA (2001).
39. GEIER MR, GEIER DA: Neurodevelopmental disorders following thimerosal-containing childhood vaccines. Exp. Biol. Med. (2003) 228:660-664.
40. GEIER MR, GEIER DA: Thimerosal in childhood vaccines, neurodevelopment disorders, and heart disease in the United States. J. Am. Phys. Surg. (2003) 8:6-11.
41. GEIER DA, GEIER MR: An assessment of the impact of thimerosal on neurodevelopmental disorders. Pediatr. Rehabil. (2003) 6:97-102.
42. CHEN RT, GLASSER JW, RHODES PH et al.: Vaccine Safety Datalink project: A new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics (1997) 99:765-773.
43. BARLOW WE, DAVIS RL, GLASSER JW et al.: The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N. Engl. J. Med. (2001) 345:656-661.
44. GEIER DA, GEIER MR: Lyme vaccination safety. J. Spirochet. Tick-Borne Dis. (2002) 9:16-22.
45. GEIER MR, GEIER DA: A follow-up examination of Lyme vaccination safety. J. Spirochet. Tick-Borne Dis. (In Press).